Table of Contents
BENTHAM SCIENCE PUBLISHERS LTD.
End User License Agreement (for non-institutional, personal use)
Usage Rules:
Disclaimer:
Limitation of Liability:
General:
FOREWORD
PREFACE
List of Contributors
Drug Discovery from Plant Sources: Scope, Approach and Challenges
Abstract
1. INTRODUCTION
2. ADVANTAGES OF DRUG DISCOVERY FROM NATURAL RESOURCES
3. ROLE OF MEDICINAL PLANTS IN DRUG DISCOVERY
4. STEPS OF DRUG DISCOVERY FROM HIGHER PLANTS
5. DRUG DISCOVERY FROM HIGHER PLANTS: APPROACHES
5.1. Ethno-Pharmacological Approach
5.2. Follow-up of Pharmacological Reports
5.3. Random Selection Followed by Phytochemical Screening
5.4. Random Selection Followed by Pharmacological Screening
6. CHALLENGES IN DRUG DISCOVERY FROM HIGHER PLANTS
CONCLUDING REMARKS
ABBREVIATIONS
CONSENT FOR PUBLICATION
CONFLICT OF INTEREST
ACKNOWLEDGEMENTS
REFERENCES
Cultivation, Collection and Processing of Medicinal Plants
Abstract
1. IMPORTANCE OF MEDICINAL PLANTS
2. CULTIVATION OF MEDICINAL PLANTS
2.1. Method of Propagation
2.1.1. Sexual or Seed Propagation
2.1.2. Asexual or Vegetative Propagation
3. FACTORS AFFECTING CULTIVATION
3.1. Soil
3.2. Altitude, Temperature and Humidity
3.3. Rainfall and Irrigation
3.4. Fertilizers
3.5. Pest and Pest Management
3.5.1. Methods of Pest Control
3.5.1.1. Natural Controls
3.5.1.2. Artificial Control
3.5.1.3. Machine-like Mechanical Control
3.5.1.4. Agricultural Control
3.5.1.5. Chemical Controls
4. ROLE OF PLANT GROWTH REGULATORS
4.1. Auxins
4.2. Gibberellins
4.3. Cytokinins
4.4. Abscisic Acid
4.5. Ethylene
4.6. Other Growth Regulators
5. ORGANIC FARMING
6. COLLECTION OF MEDICINAL PLANTS
7. HARVESTING OF MEDICINAL PLANTS
8. DRYING OF MEDICINAL PLANTS
8.1. Natural Drying
8.2. Artificial Drying
8.2.1. Tray Drying
8.2.2. Vacuum Drying
8.2.3. Spray Drying
9. GARBLING OF MEDICINAL PRODUCTS
10. PACKING OF MEDICINAL PRODUCTS
11. STORAGE AND PRESERVATION OF MEDICINAL PLANTS
CONCLUDING REMARKS
abbreviations
CONSENT FOR PUBLICATION
CONFLICT OF INTEREST
ACKNOWLEDGEMENTS
REFERENCES
Extraction of Bioactive Phytochemicals
Abstract
1. INTRODUCTION
2. STEPS INVOLVED IN THE EXTRACTION OF MEDICINAL PLANTS
2.1. Drying and Grinding of Plant Materials
2.2. Selection of Suitable Solvents
2.3. Extraction Process
2.4. Filtration
2.5. Concentration
2.6. Drying of Extract
3. FACTORS AFFECTING EXTRACTION PROCESS
4. METHODS OF EXTRACTION
4.1. Classical Methods of Extraction
4.1.1. Maceration
4.1.2. Decoction
4.1.3. Percolation
4.1.4. Reflux Extraction
4.1.5. Soxhlet Extraction
4.1.6. Isolation of Essential Oils
4.2. Modern Methods of Extraction
4.2.1. Ultrasound-Assisted Extraction (UAE)
4.2.2. Microwave-Assisted Extraction (MAE)
4.2.3. Pressurized Liquid Extraction (PLE)
4.2.4. Supercritical Fluid Extraction (SFE)
4.2.5. Enzyme Assisted Extraction (EAE)
5. CASE STUDIES: Bioactive Phytochemical Isolation and Purification
5.1. Piperine
5.2. Piperine Isolation
5.6. Starch
5.8. Artemisinin
Isolation
6. CONCLUDING REMARKS
CONSENT FOR PUBLICATION
CONFLICT OF INTEREST
ACKNOWLEDGEMENTS
REFERENCES
Isolation and Purification of Bioactive Phytochemicals
Abstract
1. INTRODUCTION
2. TECHNIQUES OF NATURAL PRODUCT ISOLATION
2.1. Counter-Current Chromatography (CCC)
2.2. Column Chromatography (CC)
2.3. Medium Pressure Liquid Chromatography (MPLC)
2.4. Preparative HPLC
2.5. Preparative Gas Chromatography (Prep-GC)
2.6. Preparative TLC (Prep-TLC)
CONCLUDING REMARKS
ABBREVIATIONS
CONSENT FOR PUBLICATION
CONFLICT OF INTEREST
ACKNOWLEDGEMENTS
REFERENCES
Spectroscopic Techniques for the Structural Characterization of Bioactive Phytochemicals
Abstract
1. INTRODUCTION
2. STRUCTURAL ELUCIDATION OF PHYTOCONSTITUENTS
2.1. UV-Visible Spectroscopy
2.2. Fourier Transform Infrared (FT-IR) Spectroscopy
2.3. NMR Spectroscopy
2.4. Mass Spectrometry
ESI MS Mass Spectrometry
3. CASE STUDIES: Some examples of structural characterization of natural products
3.1. Erythrocentaurine (EC)
3.2. Octatriacontanoic Acid (OA)
3.3. Norgadosic acid (NA)
3.4. Isoalantolactone (IL)
3.5. Quercetin (QC)
CONCLUDING REMARKS
ABBREVIATIONS
CONSENT FOR PUBLICATION
CONFLICT OF INTEREST
ACKNOWLEDGEMENTS
REFERENCES
Pharmacological Evaluation of Herbal Medicine
Abstract
1. INTRODUCTION
2. COMMON LABORATORY ANIMALS
2.1. Albino Rats (Rattus Norvegicus)
2.2. Albino Mice (Mus musculus)
2.3. C57BL/6 (B6) Black Mice
2.4. Guinea Pigs (Cavia porcellus)
2.5. Rabbits (Lupas cuniculus)
3. ETHICS OF ANIMAL EXPERIMENTATION
3.1. Objectives of Anesthesia
3.2. Pre-Anesthetic Medications
3.3. Drugs
3.4. Standard Bleeding Techniques [3]
3.5. Euthanasia
3.6. Types of Euthanasia
3.6.1. Physical Methods
3.6.1.1. Chemical Methods
3. PHARMACOLOGICAL EVALUATION METHODS
3.1. Evaluation of Analgesic Activity of Herbal Medicine
3.1.1. Hotplate Analgesiometer Method
3.1.2. Tail Clip Method
3.1.3. Tail Flick Method
3.1.4. Acetic Acid-Induced Writhing
3.2. Evaluation of Anti-Inflammatory Activity of Herbal Medicine
3.3. Evaluation of Pupil Size Effects of Herbal Medicine
3.4. Evaluation of the Hypnotic Effect of Herbal Medicine
3.5. Evaluation of Muscle Relaxant Activity of Herbal Medicine
3.6. Evaluation Of Anti-Anxiety Effect Of Herbal Medicine
3.7. Evaluation of Local Anesthetic Activity of Herbal Medicine
3.8. Evaluation of Anti-Peptic-Ulcer Activity of Herbal Medicine
3.8.1. Ethanol-Induced Ulcer Model
3.8.2. Pylorus Ligation Method (Shay Method)
3.8.3. Indomethacin Induced Ulcer
3.8.4. Assessment of Gastric Mucosal Lesions
3.9. Evaluation of Anti-Depressant Effect of Herbal Medicine
3.10. Evaluation of Anti-AtherosclerosisActivity of Herbal Medicine
3.11. Evaluation of Anti-diabetic Activity of Herbal Medicine
3.12. Evaluation ofAnti-asthmatic Effect of Herbal Medicine
3.13. Evaluation of Locomotor Activity of Herbal Medicine
CONCLUSION
CONSENT FOR PUBLICATION
CONFLICT OF INTEREST
ACKNOWLEDGEMENTS
abbreviations
REFERENCES
Product Development of Herbal Medicine
Abstract
1. INTRODUCTION
1.1. Scope of Herbal Medicinal Products
2. CHALLENGES IN HERBAL MEDICINAL PRODUCT DEVELOPMENT
3. DOSAGE FORMS OF HERBAL MEDICINAL PRODUCTS
3.1. Solid Dosage Form
3.2. Liquid Dosage Form
3.3. Semi-Solid Dosage Forms
4. RECOMMENDATIONS IN HERBAL MEDICINAL PRODUCT DEVELOPMENT
CONCLUSION AND FUTURE DIRECTIONS
ABBREVIATIONS
CONSENT FOR PUBLICATION
CONFLICT OF INTEREST
ACKNOWLEDGEMENTS
REFERENCES
Quality Control of Herbal Medicinal Products
Abstract
1. INTRODUCTION
2. The Need of Standardization
3. METHODS OF STANDARDIZATION OF HERBAL MEDICINAL PRODUCTS
3.1. Botanical Parameters
3.1.1. Morphological Characters
3.1.2. Powder Microscopy
3.2. Physico-Chemical Parameters
3.2.1. Extractive Values
3.2.2. Ash Value
3.2.3. Loss on Drying
3.2.4. Foreign Organic Matter
3.2.5. Swelling Index
3.2.6. Foaming Index
3.2.7. Fat Content
3.2.8. Resin Content
3.2.9. Total Flavonoid Content
3.2.10. Total Phenolic Content
3.3. General Quality Parameters
3.3.1. Fluorescence Analysis
3.3.2. Powdered Drug Reaction with Chemical Reagents
3.4. Phytochemical Screening
3.5. Determination of Toxic Residues
3.5.1. Pesticide Residues
3.5.2. Aflatoxin Residue
3.5.3. Microbial Load
3.5.4. Heavy Metal Toxicity
3.6. Chromatographic Evaluation of Herbal Medicinal Products
2.6.1. Thin Layer Chromatography and RF Values
3.6.2. High Performance Thin Layer Chromatography (HPTLC)
3.6.3. High Pressure Liquid Chromatography (HPLC)
3.6.4. Gas Chromatography-Mass Spectrometry (GC-MS)
3.6.5. Liquid Chromatography-Mass Spectrometry (LC-MS)
CONCLUDING REMARKS
ABBREVIATIONS
CONSENT FOR PUBLICATION
CONFLICT OF INTEREST
ACKNOWLEDGEMENTS
REFERENCES
Regulatory perspectives of Herbal Medicinal Products
Abstract
1. INTRODUCTION
2. NEED AND CHALLENGES IN HERBAL PRODUCT REGULATIONS
3. INTERNATIONAL REGULATORY SCENARIO
3.1. The International Council for Harmonization
3.2. World Health Organization (WHO)
3.3. United States Food and Drug Administration (USFDA)
3.4. European Medicines Agency (EMA)
4. REGULATORY GUIDELINES FOR HERBAL PRODUCTS
4.1. Guidelines for Regulated Market
4.2. Guidelines for the Semi-regulated Market
4.3. Guidelines for Non-regulatory Market
5. RECOMMENDATIONS ON HERBAL MEDICINE IN PHARMACOPOEIAS
5.1. United States Pharmacopoeia
5.2. Indian Pharmacopoeia
5.3. Chinese Pharmacopoeia
5.4. European Union Pharmacopoeia
CONCLUSION
ABBREVIATIONS
CONSENT FOR PUBLICATION
CONFLICT OF INTEREST
ACKNOWLEDGEMENTS
REFERENCES
Phytochemicals for the Treatment of Human Diseases
Abstract
1. INTRODUCTION
2. HERBAL MEDICINES WITH ANTIDIABETIC ACTIVITY
2.1. Current Therapies for Diabetes Mellitus
2.2. Bioactive Phytochemicals with Antidiabetic Activity
2.2.1. Charantin
2.2.2. Swertiamarin
2.2.3. Gymnemic Acids
2.2.4. Oleuropein
2.2.5. Berberine
2.2.6. 4-Hydroxyisoleucine
2.2.7. Epicatechin
2.2.8. β-Sitosterol
3. HERBAL MEDICINES WITH ANTICANCER ACTIVITY
3.1. Bioactive Phytochemicals with Anticancer Activity
3.1.1. Vincristine and Vinblastine
3.1.2. Podophyllotoxins
3.1.3. Taxanes
3.1.4. Camptothecins
3.1.5. Colchicine
3.1.6. Resveratrol
4. HERBAL MEDICINES WITH ANTI-INFLAMMATORY AND ANTIOXIDANT POTENTIAL
4.1. Current Therapies for Inflammation
4.2. Bioactive Phytochemicals with Anti-inflammatory and Antioxidant Activity
5. HERBAL MEDICINES WITH CARDIOPROTECTIVE ACTIVITY
5.1. Current Therapies for Treatment of Cardiovascular Diseases
5.1. Medicinal Plants and Bioactive Phytochemicals for Treatment of Cardiovascular Diseases
6. HERBAL MEDICINES WITH ANTIOBESITY ACTIVITY
6.1. Current Strategies for Management of Obesity
6.2. Role of Herbal Medicines for the Treatment of Obesity
CONCLUDING REMARKS
ABBREVIATIONS
CONSENT FOR PUBLICATION
CONFLICT OF INTEREST
ACKNOWLEDGEMENTS
Bioactive Phytochemicals:
Drug Discovery to Product Development
Edited by
Javed Ahmad
College of Pharmacy,
Najran University,
KSA
Co-editor
Javed Ahamad
Department of Pharmacognosy,
Faculty of Pharmacy,
Tishk International University,
Kurdistan Region, Erbil,
Iraq
BENTHAM SCIENCE PUBLISHERS LTD.
End User License Agreement (for non-institutional, personal use)
This is an agreement between you and Bentham Science Publishers Ltd. Please read this License Agreement carefully before using the ebook/echapter/ejournal (“Work”). Your use of the Work constitutes your agreement to the terms and conditions set forth in this License Agreement. If you do not agree to these terms and conditions then you should not use the Work.
Bentham Science Publishers agrees to grant you a non-exclusive, non-transferable limited license to use the Work subject to and in accordance with the following terms and conditions. This License Agreement is for non-library, personal use only. For a library / institutional / multi user license in respect of the Work, please contact: [email protected].
Usage Rules:
All rights reserved: The Work is the subject of copyright and Bentham Science Publishers either owns the Work (and the copyright in it) or is licensed to distribute the Work. You shall not copy, reproduce, modify, remove, delete, augment, add to, publish, transmit, sell, resell, create derivative works from, or in any way exploit the Work or make the Work available for others to do any of the same, in any form or by any means, in whole or in part, in each case without the prior written permission of Bentham Science Publishers, unless stated otherwise in this License Agreement.You may download a copy of the Work on one occasion to one personal computer (including tablet, laptop, desktop, or other such devices). You may make one back-up copy of the Work to avoid losing it.The unauthorised use or distribution of copyrighted or other proprietary content is illegal and could subject you to liability for substantial money damages. You will be liable for any damage resulting from your misuse of the Work or any violation of this License Agreement, including any infringement by you of copyrights or proprietary rights.
Disclaimer:
Bentham Science Publishers does not guarantee that the information in the Work is error-free, or warrant that it will meet your requirements or that access to the Work will be uninterrupted or error-free. The Work is provided "as is" without warranty of any kind, either express or implied or statutory, including, without limitation, implied warranties of merchantability and fitness for a particular purpose. The entire risk as to the results and performance of the Work is assumed by you. No responsibility is assumed by Bentham Science Publishers, its staff, editors and/or authors for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products instruction, advertisements or ideas contained in the Work.
Limitation of Liability:
In no event will Bentham Science Publishers, its staff, editors and/or authors, be liable for any damages, including, without limitation, special, incidental and/or consequential damages and/or damages for lost data and/or profits arising out of (whether directly or indirectly) the use or inability to use the Work. The entire liability of Bentham Science Publishers shall be limited to the amount actually paid by you for the Work.
General:
Any dispute or claim arising out of or in connection with this License Agreement or the Work (including non-contractual disputes or claims) will be governed by and construed in accordance with the laws of Singapore. Each party agrees that the courts of the state of Singapore shall have exclusive jurisdiction to settle any dispute or claim arising out of or in connection with this License Agreement or the Work (including non-contractual disputes or claims).Your rights under this License Agreement will automatically terminate without notice and without the need for a court order if at any point you breach any terms of this License Agreement. In no event will any delay or failure by Bentham Science Publishers in enforcing your compliance with this License Agreement constitute a waiver of any of its rights.You acknowledge that you have read this License Agreement, and agree to be bound by its terms and conditions. To the extent that any other terms and conditions presented on any website of Bentham Science Publishers conflict with, or are inconsistent with, the terms and conditions set out in this License Agreement, you acknowledge that the terms and conditions set out in this License Agreement shall prevail.
Bentham Science Publishers Pte. Ltd.
80 Robinson Road #02-00
Singapore 068898
Singapore
Email: [email protected]
FOREWORD
Plants have always considered been as ‘Nature’s Library’ for new chemical entities and one of the major resources in drug discovery and new drug development. Medicinal plants that have been used in traditional systems of medicine are being studied more than a fine decade for scientific evaluation and validation of the application, which provides rational and evidence-based alternative medicines and eventually a backbone of modern day’s herbal drug, herbal bioactives, semisynthetic and to some extent in synthetic drug and pharmaceutical industries.
In the light of the foregoing, this Book, "Bioactive Phytochemicals: Drug Discovery to Product Development" is a tremendously important and in-depth contribution to the subject of Phyto-pharmaceuticals from drug discovery to product development. The book has brought together diverse works in the scientific literature under an umbrella on the use of therapeutically active phytochemicals in the treatment of various chronic disorders. An excellent effort has been made in this frankly speaking 'a much-needed book' to address the challenges in plant and plant bioactive based drug development to its transition to the phytopharmaceutical product comprehensively and sequentially. I am confident that the book is capable of centering the attention of the reader on the limitless potentials of bioactive phytochemicals. It does particularly well too in highlighting several current areas of interest in extraction, isolation, structural characterization, pharmacological screening, product development and regulatory perspectives of herbal drugs and bioactive phytochemicals.
I have, no doubt, that this book will be well-received (equally) by the researchers in the phytopharmaceutical industry and academia. Moreover, this book is really good at offering a vast knowledge on this subject to the chemist and pharmacy students.
Dr. Sohail Akhter
Principal Scientist
New Product development, Global R & D
Teva Pharmaceuticals
Runcorn, United Kingdom
PREFACE
Early man explored natural surroundings such as plants, animals, and minerals to find the remedies of different ailments. An alternative system of medicines such as Ayurveda, Unani, Kampo, and traditional Chinese medicinal products are used as dietary supplements and nutraceuticals reported to become a major part in the treatment of chronic disorders such as diabetes, cancer, malaria, arthritis, inflammation, liver disorders, and cardiac disorders. WHO Traditional Medicine Programme is also designed on the potential of ethnomedicine as a lead for drug discovery. Compounds from plants have been extracted to investigate novel therapeutics since the origin of medicine. Natural bioactive compounds from medicinal plants are inexplicably diverse in chemical structure, biological properties and the unmet therapeutic requirements attribute to develop an interest in the reemergence of bioactive natural compounds that will lead to isolation, structural characterization and finding pharmaceutical activity.
The book discusses the scope and approaches of drug discovery from natural products; cultivation, collection and processing of medicinal plants; Methods and high throughput techniques for extraction, isolation, and characterization of bioactive phytochemicals; pharmacological screening for its activity and formulation development as well as quality control of natural medicinal products. It also discusses the regulations specified for natural medicinal products in a different region of the world. The last chapter of the book is devoted to discuss the role of natural herbal products for the treatment of human diseases such as cancer, cardiovascular diseases, diabetes, obesity, inflammation, and neurological disorders. Each chapter concludes with a general reference section, which is a bibliographic guide to more advanced texts.
This book will provide in-depth information and comprehensive discussion on extraction, isolation, structural characterization, pharmacological screening of bioactive phytochemicals as well as product development and regulatory perspective of herbal medicine. Researchers, industries, and students would be interested in this concise body of information. The contributing authors are drawn from a rich blend of experts in various areas of herbal medicine encompass drug discovery to product development.
Dr. Javed Ahmad
College of Pharmacy
Najran University
KSACo-editorJaved Ahamad
Department of Pharmacognosy,
Faculty of Pharmacy,
Tishk International University,
Kurdistan Region, Erbil,
Iraq
List of Contributors
Samad Abdul, Department of Pharmaceutical ChemistryFaculty of Pharmacy, Tishk International UniversityKurdistan RegionIraqSalma Afrin, Department of Pharmaceutical ChemistryTranslum Institute of Pharmaceutical Education and ResearchMeerut (UP)IndiaKhan Ahmed Nawaz, School of PharmacyGraphic Era Hill UniversityDehradun Uttarakhand, 248002IndiaAli Asad, Department of ChemistrySchool of Chemical and Life Sciences, Jamia Hamdard UniversityNew DelhiIndiaKala Chandra, Faculty of Pharmacy Maulana Azad UniversityJodhpur, Rajasthan, 342802IndiaPatel Dinesh Kumar, Department of Pharmaceutical ScienceSam Higginbottom, University of Agricultural Tech. and ScienceIndiaAnwer Esra T., Department of PharmaceuticsFaculty of Pharmacy, Tishk International UniversityKurdistan RegionIraqAli Faraat, Laboratory ServicesBotswana Medicines Regulatory Authority, Plot 112 International Finance ParkGaboroneBotswanaDubey Govind Prasad, Study Director and Coordinator - Collaborative ProgramInstitute of Medical Sciences, Banaras Hindu UniversityVaransiIndiaFirdous Jamia, Department of PharmacyInstitute of Bio-Medical Education and Research, Mangalayatan UniversityAligarhIndiaAlbert Jaswanth, Faculty of PharmacologySurabhi Dayakar Rao College of Pharmacy, Gajwel, Rimmanaguda, HyderabadTelanganaIndiaAhamad Javed , Department of PharmacognosyFaculty of Pharmacy, Tishk International University, ErbilKurdistan RegionIraqAhmad Javed, Department of PharmaceuticsCollege of Pharmacy, Najran UniversityKingdom of Saudi ArabiaSharma Kamna, Department of Pharmaceutical AnalysisIndo-Soviet Friendship College of PharmacyMoga, PunjabIndiaNaquvi Kamran Javed, Department of Pharmacognosy & PhytochemistryFaculty of Pharmaceutical Sciences, Rama University, Rama City, MandhanaKanpur (Uttar Pradesh) - 209 217IndiaTrivedi Manisha, NIMS UniversityJaipur, RajasthanIndiaAkhtar Mohammad Shabib, Department of Clinical PharmacyCollege of Pharmacy, Najran UniversityNajranKingdom of Saudi ArabiaAmeen Muath Sh. Mohammed, Department of PharmaceuticsFaculty of Pharmacy, Tishk International UniversityKurdistan RegionIraqAlkefai Naila Hassan Ali, Department of PharmacognosyFaculty of Pharmacy, University of Hafer AlbatinHafer AlbatinKSAMohsin Nehal, Department of Clinical PharmacyCollege of Pharmacy, Najran UniversityNajranKingdom of Saudi ArabiaPorwal Omji, Department of PharmacognosyFaculty of Pharmacy, Tishk International University, ErbilKurdistan RegionIraqKaskoos Raad A, Faculty of PharmacyHowler Medical UniversityKurdistan RegionIraqTripathi Rahul, Medpharm Pharmaceutical Ltd.GuilfordUnited KingdomSingh Sachin, School of pharmaceutical SciencesLovely professional University, Phagwara-144411PunjabIndiaGupta Saurabh, Department of PharmacologyChitkara University, Jansla, RajpuraPunjab 140401IndiaKhasimbi Shaik, Department of Pharmaceutical Chemistry, Delhi Institute of Pharmaceutical Sciences and Research (DIPSAR)Mehrauli-Badarpur Road, PushVihar, Sector-3New Delhi, 110017IndiaKatekhaye Shankar, Center for pharmaceutical Engineering Science University of BarfordBarford-BD71DPUnited KingdomNajibullah Shehla Nasar Mir, Department of PharmacognosyFaculty of PharmacyKing Khalid University, AbhaKSAMir Showkat R., Department of PharmacognosySchool of Pharmaceutical Education and Research, Jamia HamdardNew DelhiIndiaUthirapathy Subasini, Department of PharmacologyFaculty of Pharmacy, Tishk International UniversityKRGIraqTahir Tara Fuad, Faculty of Science and HealthKoya UniversityKurdistan RegionIraq
Drug Discovery from Plant Sources: Scope, Approach and Challenges
Javed Ahmad1,Javed Ahamad2,*
1 Department of Pharmaceutics, College of Pharmacy, Najran University, Kingdom of Saudi Arabia
2 Department of Pharmacognosy, Faculty of Pharmacy, Tishk International University, Erbil, Kurdistan Region, Iraq
Abstract
Medicinal plants are recognized to fulfill human necessities like food, clothes, shelter and health. The search for eternal health and longevity to seek remedy to relieve discomfort prompted mankind to develop many ways and means of health care systems. Traditional medicines were practiced in ancient civilizations for the cure of ailments. In recent years, natural products play a very important role in drug discovery for life-threatening ailments like cancer, malaria, diabetes and cardiovascular problems. Recently, drug discovery from plants for the treatment of cancer gets more focused and leads to the discovery of novel anticancer drugs such as paclitaxel, docetaxel, topotecan, irinotecan, vincristine and vinblastine. Drug discovery from plants is a long and tedious process, and it requires selecting suitable plants, pre-clinical screening, clinical evaluation and drug approval for marketing. Herbal medicines obtained from plants are generally considered safe compared to synthetic drugs, and secondary metabolites obtained from plants have more chemical diversity and considered superior to synthetic combinatorial chemicals. In this book chapter, we comprehensively discussed the advantages and role of higher plants in drug discovery, steps and approaches of drug discovery from higher plants.
Keywords: Approaches of Drug Discovery, Cancer, Drug Discovery, Diabetes, Malaria, Natural Products, Plants.
*Corresponding author Dr. Javed Ahamad: Department of Pharmacognosy, Faculty of Pharmacy, Tishk International University, Erbil, Kurdistan Region, Iraq; E-mails:
[email protected],
[email protected]CONSENT FOR PUBLICATION
Not applicable.
CONFLICT OF INTEREST
The authors confirm that this chapter content has no conflict of interest.
ACKNOWLEDGEMENTS
Declared none.
REFERENCES
[1]Fabricant DS, Farnsworth NR. The value of plants used in traditional medicine for drug discovery. Environ Health Perspect 2001; 109 (Suppl. 1): 69-75.[PMID: 11250806][2]Patwardhan B, Vaidya ADB, Chorghade M. Ayurveda and natural products drug discovery. Curr Sci 2004; 86(6): 789-99.[3]Bannerman RHO, Burton J, Ch’en WC. Traditional Medicine and Health Care Coverage: A Reader for Health Administrators and Practitioners 1983.[4]Trease and Evans, Pharmacognosy (16th ed.), 16th ed.Evans WC. Saunders Publication2009.[5]Farnsworth NR, Akerele O, Bingel AS, Soejarto DD, Guo Z. Medicinal plants in therapy. Bull World Health Organ 1985; 63(6): 965-81.[PMID: 3879679][6]Lahlou M. Screening of natural products for drug discovery. Expert Opin Drug Discov 2007; 2(5): 697-705.[http://dx.doi.org/10.1517/17460441.2.5.697] [PMID: 23488959][7]Dubey NK, Kumar R, Tripathi P. Global promotion of herbal medicine: India’s opportunity. Current Med 2004; 86: 37-41.[8]Grover JK, Yadav S, Vats V. Medicinal plants of India with anti-diabetic potential. J Ethnopharmacol 2002; 81(1): 81-100.[http://dx.doi.org/10.1016/S0378-8741(02)00059-4] [PMID: 12020931][9]Newman DJ, Cragg GM. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod 2016; 79(3): 629-61.[http://dx.doi.org/10.1021/acs.jnatprod.5b01055] [PMID: 26852623][10]Newman DJ, Cragg GM, Snader KM. Natural products in therapeutic. J Nat Prod 2003; 66: 1022.[http://dx.doi.org/10.1021/np030096l] [PMID: 12880330][11]Verpoorte R. Pharmacognosy in the new millennium: leadfinding and biotechnology. J Pharm Pharmacol 2000; 52(3): 253-62.[http://dx.doi.org/10.1211/0022357001773931] [PMID: 10757412][12]Shrager J. High throughput discovery: search and interpretation on the path to new drugs. Design for Science Crowley K. 2001; Vol. 11: 325-48.[13]Farnsworth NR. The role of ethnopharmacology in drug development. Ciba Found Symp 1990; 154: 2-11.[PMID: 2086037][14]Farnsworth NR. Biological and phytochemical screening of plants. J Pharm Sci 1966; 55(3): 225-76.[http://dx.doi.org/10.1002/jps.2600550302] [PMID: 5335471][15]Wall ME, Wani MC. Camptothecin and taxol: from discovery to clinic. J Ethnopharmacol 1996; 51(1-3): 239-53.[http://dx.doi.org/10.1016/0378-8741(95)01367-9] [PMID: 9213622][16]Rastogi RP, Dhawan BN. Research on medicinal plants at the central drug research institute, Lucknow (India). Indian J Med Res 1982; 76 (Suppl.): 27-45.[PMID: 6764455][17]Cragg GM, Newman DJ. International collaboration in drug discovery and development from natural sources. Pure Appl Chem 2005; 77(11): 1923-42.[http://dx.doi.org/10.1351/pac200577111923][18]Harvey A. Strategies for discovering drugs from previously unexplored natural products. Drug Discov Today 2000; 5(7): 294-300.[http://dx.doi.org/10.1016/S1359-6446(00)01511-7] [PMID: 10856912][19]Baker JT, Borris RP, Carté B, et al. Natural product drug discovery and development: new perspectives on international collaboration. J Nat Prod 1995; 58(9): 1325-57.[http://dx.doi.org/10.1021/np50123a003] [PMID: 7494142][20]Mullard A. New drugs cost US$2.6 billion to develop. Nat Rev Drug Discov 2014; 13: 877.[http://dx.doi.org/10.1038/nrd4507]
Cultivation, Collection and Processing of Medicinal Plants
Omji Porwal1,*,Sachin Kumar Singh2,Dinesh Kumar Patel3,Saurabh Gupta4,Rahul Tripathi5,Shankar Katekhaye6
1 Department of Pharmacognosy, Faculty of Pharmacy, Tishk International University, Erbil, Kurdistan, Iraq
2 School of Pharmaceutical Sciences, Lovely Professional University, Phagwara-144411, Punjab, India
3 Faculty of Health Science, Shalom Institute of Health and Allied Sciences Sam Higginbottom University of Agriculture, Technology and Sciences (SHUATS)-State University (Formerly Allahabad Agriculture Institute) Naini, Allahabad, India
4 Chitkara College of Pharmacy, Chitkara University, Chandigarh-patiala highway (NH-4), Rajpura Punjab 140401-India
5 Medpharm Pharmaceutical Ltd. Guilford, United Kingdom
6 Center for pharmaceutical Engineering Science University of Barford, Barford-BD71DP, United Kingdom
Abstract
Nature has provided us better surroundings for the expansion and development of medicinal plants for thousands of years. Medicinal values of plants date back to ancient times on belief of its safety and economic value. Even in today’s scenario, about 80% of the globe population primarily depends on the alternative system of medicines for their foremost healthcare requisite. Plants contain different types of secondary metabolites also called bioactive components of the plants responsible for their medicinal value in nature. Scientific cultivation permits the applying of contemporary technological aspects like mutation, polyploidy and hybridization for the development of a better amount of secondary metabolites from the plants and their byproducts. Cultivation, collection and preservations of medicinal plants need simple techniques that preserve the medicinal values of natural products. Pharmacological activities of medicinal and aromatic plants are mainly depending upon the presence of various bioactive phytochemicals like alkaloids, glycosides, tannins, resins, volatile oil, etc. Growth and development of medicinal plants and their secondary metabolites are mainly influenced by the physical surroundings, sunlight, temperature, rainfall, and nature of the soil. Seasonal variation and geographical region can also affect the quality of medicinal and aromatic plants as the concentration of bioactive constituent could be changed through natural factors. In the present book
chapter, we have discussed all the important information needed for the cultivation, collection and processing of medicinal and aromatic plants that affect the quality of medicinal plants.
Keywords : Cultivation, Collection, Drying, Harvesting, Medicinal Plants, Plant Growth Hormones.
*Corresponding author Omji Porwal: Department of Pharmacognosy, Faculty of pharmacy, Tishk International University, Erbil, Kurdistan Region, Iraq; Email:
[email protected]1. IMPORTANCE OF MEDICINAL PLANTS
The crude drug that reaches the market and pharmaceutical industry must have some basic characteristics and quantity of active constituents for their claim therapeutic potential. Cultivation produces a quality of plants, increases secondary metabolite concentration, generates hybrids that produce specific phytoconstituents, ensures regular supply of crude drugs and also leads industrialization, etc. The gathering of crude medicine from cultivated plants provides a higher yield and therapeutic quality. Medicinal plants require sunny, aerated places sheltered from gale and late winter frosts. The soil must be fertile and consist of the required amounts of Na, P, Cu, alloy, organic and other essential elements for the better growth of medicinal and aromatic plants. Continuation of the farming structure has become a vital affair throughout the globe. A large number of the viable matter is related to the quality and time-dependent changes in the soil [1]. It is well known that in-depth cultivation has led to a swift rebuff in organic matter and nutrient levels besides affecting the physical things of clay [1]. However, the management practices with organic materials influence agricultural properties by the physical, chemical and biological properties of clay [2]. The implementation of organic amendments has long been recognized as an efficient suggestion for the improvement in the structure and fertility of the soil [3]. Increasing the microorganism diversity, activity, population and moisture-holding capability of soils also improve crop yield [4].